NCT01476215View on ClinicalTrials.gov

A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Healthy Subjects
Interventions
DRUG

Paracetamol fast dissolution suspension

DRUG

Paracetamol medium dissolution suspension

DRUG

Paracetamol slow dissolution suspension

DRUG

Paracetamol

Trial Locations (1)

68501

MDS Pharma Services NEBRASKA, Lincoln

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01476215 - A Pharmacokinetic Study Investigating the Rate and Extent of Paracetamol Absorption of Three Experimental Sustained Release Pediatric Suspensions | Biotech Hunter | Biotech Hunter